Found: 4
Select item for more details and to access through your institution.
Five‐year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma.
- Published in:
- Journal of Dermatology, 2021, v. 48, n. 5, p. 592, doi. 10.1111/1346-8138.15804
- By:
- Publication type:
- Article
Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignancies.
- Published in:
- International Journal of Hematology, 2023, v. 117, n. 4, p. 553, doi. 10.1007/s12185-022-03514-6
- By:
- Publication type:
- Article
Final analysis of a phase II study of nivolumab in combination with ipilimumab for unresectable chemotherapy‐naive advanced melanoma.
- Published in:
- Journal of Dermatology, 2020, v. 47, n. 11, p. 1257, doi. 10.1111/1346-8138.15514
- By:
- Publication type:
- Article
Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma.
- Published in:
- Cancer Science, 2019, v. 110, n. 6, p. 1995, doi. 10.1111/cas.14015
- By:
- Publication type:
- Article